Michael Link

Medical oncologist

Lydia J. Lee Professor in Pediatric Cancer

Lymphoma Program

  • 875 Blake Wilbur Drive
  • Palo Alto, CA 94304
  • Phone: 650-498-6000
Learn More About the Clinic Getting Here Make An Appointment

Professional Education

Board Certification: Pediatrics, American Board of Pediatrics (1979)

Fellowship: Children's Hospital Boston (1979) MA

Residency: Children's Hospital Boston (1976) MA

Internship: Children's Hospital Boston (1975) MA

Board Certification: Pediatric Hematology-Oncology, American Board of Pediatrics (1980)

Fellowship: Dana-Farber Cancer Institute (1979) MA

Medical Education: Stanford University School of Medicine (1974) CA

MD, Stanford University, Medicine (1974)

AB, Columbia College, Political Science (1970)

Honors & Awards

Honorary Fellow, The Royal Academy of Paediatrics and Child Health (June, 2013)

21st Annual W.W. Sutow Visiting Lecturer in Pediatric Oncology, MD Anderson Hospital (2013)

Brent Eley Visiting Professor in Pediatric Oncology, University of Colorado Cancer Center and the Childrens Hospital, Denver (2009)

Annual Memorial Lectureship, Pediatric Cancer Research Foundation (2004)

Ben Abelson Memorial Visiting Professor, Washington University School of Medicine (2000)

Alpha Omega Alpha, Alpha Omega Alpha (1974)

Phi Beta Kappa, Phi Beta Kappa (1969)

Administrative Appointments

President, American Society of Clinical Oncology (2011 - 2012)

President-Elect, American Society of Clinical Oncology (2010 - 2011)

Lydia J. Lee Professor in Pediatric Cancer, Stanford University (2003 - Present)

Chief, Division of Pediatric Hematology/Oncology, Stanford University School of Medicine (2000 - 2010)

Director, Center for Cancer and Blood Diseases, Lucile Packard Children's Hospital at Stanford (2002 - 2010)

Clinical Trials

Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.

Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.

Adolescent and Young Adult Oncology, Version 2.2014
Coccia, P. F., Pappo, A. S., Altman, J., Bhatia, S., Borinstein, S. C., & Sundar, H. (2014). Adolescent and Young Adult Oncology, Version 2.2014. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 12(1), 21-32.

Relapse after treatment of pediatric hodgkin lymphoma: Outcome and role of surveillance after end of therapy
Friedmann, A. M., Wolfson, J. A., Hudson, M. M., Weinstein, H. J., Link, M. P., & Metzger, M. L. (2013). Relapse after treatment of pediatric hodgkin lymphoma: Outcome and role of surveillance after end of therapy. PEDIATRIC BLOOD & CANCER, 60(9), 1458-1463.

The Impact of Drug Shortages on Children with Cancer - The Example of Mechlorethamine
Metzger, M. L., Billett, A., & Link, M. P. (2012). The Impact of Drug Shortages on Children with Cancer - The Example of Mechlorethamine. NEW ENGLAND JOURNAL OF MEDICINE, 367(26), 2461-2463.

Extremely low-frequency magnetic fields and survival from childhood acute lymphoblastic leukemia: an international follow-up study
Schuz, J., Grell, K., Kinsey, S., Linet, M. S., Link, M. P., & Frederiksen, K. (2012). Extremely low-frequency magnetic fields and survival from childhood acute lymphoblastic leukemia: an international follow-up study. BLOOD CANCER JOURNAL, 2.

Adolescent and Young Adult Oncology
Coccia, P. F., Altman, J., Bhatia, S., Borinstein, S. C., Flynn, J., & Zebrack, B. J. (2012). Adolescent and Young Adult Oncology. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 10(9), 1112-1150.

ALK+ anaplastic large cell lymphoma exhibits phosphatidylinositol-3 kinase/akt activity with retained but inactivated PTEN-A report from the Children's Oncology Group
Thakral, C., Hutchison, R. E., Shrimpton, A., Barrett, D., Laver, J., & Hudson, S. (2012). ALK+ anaplastic large cell lymphoma exhibits phosphatidylinositol-3 kinase/akt activity with retained but inactivated PTEN-A report from the Children's Oncology Group. PEDIATRIC BLOOD & CANCER, 59(3), 440-447.

Association Between Radiotherapy vs No Radiotherapy Based on Early Response to VAMP Chemotherapy and Survival Among Children With Favorable-Risk Hodgkin Lymphoma
Metzger, M. L., Weinstein, H. J., Hudson, M. M., Billett, A. L., Larsen, E. C., & Link, M. P. (2012). Association Between Radiotherapy vs No Radiotherapy Based on Early Response to VAMP Chemotherapy and Survival Among Children With Favorable-Risk Hodgkin Lymphoma. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 307(24), 2609-2616.

Chemotherapy Drug Shortages in the United States: Genesis and Potential Solutions
Link, M. P., Hagerty, K., & Kantarjian, H. M. (2012). Chemotherapy Drug Shortages in the United States: Genesis and Potential Solutions. JOURNAL OF CLINICAL ONCOLOGY, 30(7), 692-694.

Complete Ocular Paresis in a Child with Posterior Fossa Syndrome
Afshar, M., Link, M., Edwards, M. Sb., Fisher, P. G., Fredrick, D., & Monje, M. (2012). Complete Ocular Paresis in a Child with Posterior Fossa Syndrome. PEDIATRIC NEUROSURGERY, 48(1), 51-54.

Second Malignant Neoplasms in Survivors of Pediatric Hodgkin's Lymphoma Treated With Low-Dose Radiation and Chemotherapy
O'Brien, M. M., Donaldson, S. S., Balise, R. R., Whittemore, A. S., & Link, M. P. (2010). Second Malignant Neoplasms in Survivors of Pediatric Hodgkin's Lymphoma Treated With Low-Dose Radiation and Chemotherapy. JOURNAL OF CLINICAL ONCOLOGY, 28(7), 1232-1239.

The Impact of the Privacy Rule on Cancer Research: Variations in Attitudes and Application of Regulatory Standards
Goss, E., Link, M. P., Bruinooge, S. S., Lawrence, T. S., Tepper, J. E., & Schilsky, R. L. (2009). The Impact of the Privacy Rule on Cancer Research: Variations in Attitudes and Application of Regulatory Standards. JOURNAL OF CLINICAL ONCOLOGY, 27(24), 4014-4020.

Non-anaplastic peripheral T-cell lymphoma in childhood and adolescence: A children's oncology group study
Hutchison, R. E., Laver, J. H., Chang, M., Muzzafar, T., Desai, S., & Link, M. P. (2008). Non-anaplastic peripheral T-cell lymphoma in childhood and adolescence: A children's oncology group study. PEDIATRIC BLOOD & CANCER, 51(1), 29-33.

Nodular lymphocyte-predominant Hodgkin lymphoma presenting as fulminant hepatic failure in a pediatric patient: A case report with pathologic, immunophenotypic, and molecular findings
Woolf, K. Mw., Wei, M. C., Link, M. P., Arber, D. A., & Warnke, R. A. (2008). Nodular lymphocyte-predominant Hodgkin lymphoma presenting as fulminant hepatic failure in a pediatric patient: A case report with pathologic, immunophenotypic, and molecular findings. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 16(2), 196-201.

Osteosarcoma: The addition of muramyl tripeptide to chemotherapy improves overall survival - A report from the Children's Oncology Group
Meyers, P. A., Schwartz, C. L., Krailo, M. D., Healey, J. H., Bernstein, M. L., & Grier, H. E. (2008). Osteosarcoma: The addition of muramyl tripeptide to chemotherapy improves overall survival - A report from the Children's Oncology Group. JOURNAL OF CLINICAL ONCOLOGY, 26(4), 633-638.

Treatment of metastatuc Ewing Sarcoma/Primitive neuroectodermal tumor of bone: Evaluation of increasing the dose intensity of chemotherapy - A report from the children's oncology group
Miser, J. S., Goldsby, R. E., Chen, Z., Krailo, M. D., Tarbell, N. J., & Grier, H. E. (2007). Treatment of metastatuc Ewing Sarcoma/Primitive neuroectodermal tumor of bone: Evaluation of increasing the dose intensity of chemotherapy - A report from the children's oncology group. PEDIATRIC BLOOD & CANCER, 49(7), 894-900.

Final results of a prospective clinical trial with VAMP and low-dose involved-field radiation for children with low-risk Hodgkin's disease
Donaldson, S. S., Link, M. P., Weinstein, H. J., Rai, S. N., Brain, S., & Hudson, M. M. (2007). Final results of a prospective clinical trial with VAMP and low-dose involved-field radiation for children with low-risk Hodgkin's disease. JOURNAL OF CLINICAL ONCOLOGY, 25(3), 332-337.

Therapy-related myelodysplasia and acute myeloid leukemia after Ewing sarcoma and primitive neuroectodermal tumor of bone: a report from the Children's Oncology Group
Bhatia, S., Krailo, M. D., Chen, Z., Burden, L., Askin, F. B., & Miser, J. S. (2007). Therapy-related myelodysplasia and acute myeloid leukemia after Ewing sarcoma and primitive neuroectodermal tumor of bone: a report from the Children's Oncology Group. BLOOD, 109(1), 46-51.

Magnetic field exposure and prognostic factors in childhood leukemia
Foliart, D. E., Mezei, G., Iriye, R., Silva, J. M., Ebi, K. L., & Pollock, B. H. (2007). Magnetic field exposure and prognostic factors in childhood leukemia. BIOELECTROMAGNETICS, 28(1), 69-71.

Magnetic field exposure and long-term survival among children with leukaemia
Foliart, D. E., Pollock, B. H., Mezei, G., Iriye, R., Silva, J. M., & Kavet, R. (2006). Magnetic field exposure and long-term survival among children with leukaemia. BRITISH JOURNAL OF CANCER, 94(1), 161-164.

Intensive therapy with growth factor support for patients with Ewing tumor metastatic at diagnosis: Pediatric oncology group/children's cancer group phase II study 9457 - A report from the children's oncology group
Bernstein, M. L., Devidas, M., LaFreniere, D., Souid, A. K., Meyers, P. A., & Grier, H. E. (2006). Intensive therapy with growth factor support for patients with Ewing tumor metastatic at diagnosis: Pediatric oncology group/children's cancer group phase II study 9457 - A report from the children's oncology group. JOURNAL OF CLINICAL ONCOLOGY, 24(1), 152-159.

Review of tonsillar lymphoma in pediatric patients from the Pediatric Oncology Group: What can be learned about some indications for microscopic examination?
Sayed, K., Savell, V. H., Hutchison, R. E., Kepner, J., Link, M. P., & Parham, D. M. (2005). Review of tonsillar lymphoma in pediatric patients from the Pediatric Oncology Group: What can be learned about some indications for microscopic examination?. PEDIATRIC AND DEVELOPMENTAL PATHOLOGY, 8(5), 533-540.

Osteosarcoma: A randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate
Meyers, P. A., Schwartz, C. L., Krailo, M., Kleinerman, E. S., Betcher, D., & Grier, H. (2005). Osteosarcoma: A randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate. JOURNAL OF CLINICAL ONCOLOGY, 23(9), 2004-2011.

Epstein-Barr virus-associated peripheral T-cell lymphoma and hemophagocytic syndrome arising after liver transplantation: Case report and review of the literature
George, T. I., Jeng, M., Berquist, W., Cherry, A. M., Link, M. P., & Arber, D. A. (2005). Epstein-Barr virus-associated peripheral T-cell lymphoma and hemophagocytic syndrome arising after liver transplantation: Case report and review of the literature. PEDIATRIC BLOOD & CANCER, 44(3), 270-276.

High-dose therapy and autologous hematopoietic stem-cell transplantation for recurrent or refractory pediatric Hodgkin's disease: Results and prognostic indices
Lieskovsky, Y. E., Donaldson, S. S., Torres, M. A., Wong, R. M., Amylon, M. D., & Agarwal, R. (2004). High-dose therapy and autologous hematopoietic stem-cell transplantation for recurrent or refractory pediatric Hodgkin's disease: Results and prognostic indices. JOURNAL OF CLINICAL ONCOLOGY, 22(22), 4532-4540.

Risk-adapted, combined-modality therapy with VAMP/COP and response-based, involved-field radiation for unfavorable pediatric Hodgkin's disease
Hudson, M. M., Krasin, M., Link, M. P., Donaldson, S. S., BILLUPS, C., & Weinstein, H. J. (2004). Risk-adapted, combined-modality therapy with VAMP/COP and response-based, involved-field radiation for unfavorable pediatric Hodgkin's disease. JOURNAL OF CLINICAL ONCOLOGY, 22(22), 4541-4550.

Cyclophosphamide dose intensification during induction therapy for intermediate-risk pediatric rhabdomyosarcoma is feasible but does not improve outcome: A report from the soft tissue sarcoma committee of the children's oncology group
Spunt, S. L., Smith, L. M., Ruymann, F. B., Qualman, S. J., Donaldson, S. S., & Link, M. P. (2004). Cyclophosphamide dose intensification during induction therapy for intermediate-risk pediatric rhabdomyosarcoma is feasible but does not improve outcome: A report from the soft tissue sarcoma committee of the children's oncology group. CLINICAL CANCER RESEARCH, 10(18), 6072-6079.

Treatment of metastatic Ewing's sarcoma or primitive neuroectodermal tumor of bone: Evaluation of combination ifosfamide and etoposide - A children's cancer group and pediatric oncology group study
Miser, J. S., Krailo, M. D., Tarbell, N. J., Link, M. P., Fryer, C. Jh., & Grier, H. E. (2004). Treatment of metastatic Ewing's sarcoma or primitive neuroectodermal tumor of bone: Evaluation of combination ifosfamide and etoposide - A children's cancer group and pediatric oncology group study. JOURNAL OF CLINICAL ONCOLOGY, 22(14), 2873-2876.

High-dose methotrexate pharmacokinetics and outcome of children and young adults with osteosarcoma
Crews, K. R., Liu, T., Rodriguez-Galindo, C., Tan, M., Meyer, W. H., & Daw, N. C. (2004). High-dose methotrexate pharmacokinetics and outcome of children and young adults with osteosarcoma. CANCER, 100(8), 1724-1733.

National Institutes of Health State-of-the-Science Conference Statement: Symptom management in cancer: pain, depression, and fatigue, July 15-17, 2002.
Patrick, D. L., Ferketich, S. L., Frame, P. S., Harris, J. J., Hendricks, C. B., & Vernon, S. W. (2004). National Institutes of Health State-of-the-Science Conference Statement: Symptom management in cancer: pain, depression, and fatigue, July 15-17, 2002. Journal of the National Cancer Institute. Monographs, (32), 9-16.

National Institutes of Health State-of-the-Science Conference Statement: Symptom Management in Cancer: Pain, Depression, and Fatigue, July 15-17, 2002.
Patrick, D. L., Ferketich, S. L., Frame, P. S., Harris, J. J., Hendricks, C. B., & Vernon, S. W. (2003). National Institutes of Health State-of-the-Science Conference Statement: Symptom Management in Cancer: Pain, Depression, and Fatigue, July 15-17, 2002. Journal of the National Cancer Institute, 95(15), 1110-1117.

Prognostic factors for children with Hodgkin's disease treated with combined-modality therapy
Smith, R. S., Chen, G., Hudson, M. M., Link, M. P., Kun, L., & Donaldson, S. S. (2003). Prognostic factors for children with Hodgkin's disease treated with combined-modality therapy. JOURNAL OF CLINICAL ONCOLOGY, 21(10), 2026-2033.

Presurgical chemotherapy compared with immediate surgery and adjuvant chemotherapy for nonmetastatic osteosarcoma: Pediatric oncology group study POG-8651
Goorin, A. M., Schwartzentruber, D. J., Devidas, M., Gebhardt, M. C., AYALA, A. G., & Link, M. P. (2003). Presurgical chemotherapy compared with immediate surgery and adjuvant chemotherapy for nonmetastatic osteosarcoma: Pediatric oncology group study POG-8651. JOURNAL OF CLINICAL ONCOLOGY, 21(8), 1574-1580.

Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone
Grier, H. E., Krailo, M. D., Tarbell, N. J., Link, M. P., Fryer, C. Jh., & Miser, J. S. (2003). Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone. NEW ENGLAND JOURNAL OF MEDICINE, 348(8), 694-701.

Prognostic factors and clinical outcomes in children and adolescents with metastatic rhabdomyosarcoma - A report from the intergroup rhabdomyosarcoma study IV
Breneman, J. C., Lyden, E., Pappo, A. S., Link, M. P., Anderson, J. R., & Crist, W. M. (2003). Prognostic factors and clinical outcomes in children and adolescents with metastatic rhabdomyosarcoma - A report from the intergroup rhabdomyosarcoma study IV. JOURNAL OF CLINICAL ONCOLOGY, 21(1), 78-84.

Children from ethnic minorities have benefited equally as other children from contemporary therapy for rhabdomyosarcoma: A report from the intergroup rhabdomyosarcoma study group
Baker, K. S., Anderson, J. R., Lobe, T. E., Wharam, M. D., Qualman, S. J., & Crist, W. M. (2002). Children from ethnic minorities have benefited equally as other children from contemporary therapy for rhabdomyosarcoma: A report from the intergroup rhabdomyosarcoma study group. JOURNAL OF CLINICAL ONCOLOGY, 20(22), 4428-4433.

National action plan for childhood cancer: report of the national summit meetings on childhood cancer.
Arceci, R., Ettinger, A., Forman, E., Haase, G. M., Hammond, G. D., & Traynor, D. S. (2002). National action plan for childhood cancer: report of the national summit meetings on childhood cancer. CA: a cancer journal for clinicians, 52(6), 377-379.

Assessment of lymphadenopathy in children
Twist, C. J., & Link, M. P. (2002). Assessment of lymphadenopathy in children. PEDIATRIC CLINICS OF NORTH AMERICA, 49(5), 1009-?.

Minimax two-stage-designs with applications to tissue banking case-control studies
Shuster, J., Link, M., Camitta, B., Pullen, J., & Behm, F. (2002). Minimax two-stage-designs with applications to tissue banking case-control studies. STATISTICS IN MEDICINE, 21(17), 2479-2493.

Treatment of unfavorable childhood Hodgkin's disease with VEPA and low-dose, involved-field radiation
Friedmann, A. M., Hudson, M. M., Weinstein, H. J., Donaldson, S. S., Kun, L., & Link, M. P. (2002). Treatment of unfavorable childhood Hodgkin's disease with VEPA and low-dose, involved-field radiation. JOURNAL OF CLINICAL ONCOLOGY, 20(14), 3088-3094.

VAMP and low-dose, involved-field radiation for children and adolescents with favorable, early-stage Hodgkin's disease: Results of a prospective clinical trial
Donaldson, S. S., Hudson, M. M., Lamborn, K. R., Link, M. P., Kun, L., & Weinstein, H. J. (2002). VAMP and low-dose, involved-field radiation for children and adolescents with favorable, early-stage Hodgkin's disease: Results of a prospective clinical trial. JOURNAL OF CLINICAL ONCOLOGY, 20(14), 3081-3087.

Bone marrow stroma-supported culture of T-lineage acute lymphoblastic leukemic cells predicts treatment outcome in children: a Pediatric Oncology Group study
Winter, S. S., Sweatman, J., Shuster, J. J., Link, M. P., Amylon, M. D., & Larson, R. S. (2002). Bone marrow stroma-supported culture of T-lineage acute lymphoblastic leukemic cells predicts treatment outcome in children: a Pediatric Oncology Group study. LEUKEMIA, 16(6), 1121-1126.

Dose escalation and pharmacokinetics of pegylated liposomal doxorubicin (Doxil) in children with solid tumors: A pediatric oncology group study
Marina, N. M., Cochrane, D., Harney, E., Zomorodi, K., Blaney, S., & Link, M. P. (2002). Dose escalation and pharmacokinetics of pegylated liposomal doxorubicin (Doxil) in children with solid tumors: A pediatric oncology group study. CLINICAL CANCER RESEARCH, 8(2), 413-418.

Phase II/III trial of etoposide and high-dose ifosfamide in newly diagnosed metastatic osteosarcoma: A Pediatric Oncology Group trial
Goorin, A. M., Harris, M. B., Bernstein, M., Ferguson, W., Devidas, M., & Grier, H. E. (2002). Phase II/III trial of etoposide and high-dose ifosfamide in newly diagnosed metastatic osteosarcoma: A Pediatric Oncology Group trial. JOURNAL OF CLINICAL ONCOLOGY, 20(2), 426-433.

Efficacy of ifosfamide and doxorubicin given as a phase II "window" in children with newly diagnosed metastatic rhabdomyosarcoma: A report from the Intergroup Rhabdomyosarcoma Study Group
Sandler, E., Lyden, E., Ruymann, F., Maurer, H., Wharam, M., & Crist, W. (2001). Efficacy of ifosfamide and doxorubicin given as a phase II "window" in children with newly diagnosed metastatic rhabdomyosarcoma: A report from the Intergroup Rhabdomyosarcoma Study Group. MEDICAL AND PEDIATRIC ONCOLOGY, 37(5), 442-448.

Which patients with microscopic disease and rhabdomyosarcoma experience relapse after therapy? A report from the soft tissue sarcoma committee of the children's oncology group
Smith, L. M., Anderson, J. R., Qualman, S. J., Crist, W. M., Paidas, C. N., & Donaldson, S. S. (2001). Which patients with microscopic disease and rhabdomyosarcoma experience relapse after therapy? A report from the soft tissue sarcoma committee of the children's oncology group. JOURNAL OF CLINICAL ONCOLOGY, 19(20), 4058-4064.

Controversies in the management of paratesticular rhabdomyosarcoma: is staging retroperitoneal lymph node dissection necessary for adolescents with resected paratesticular rhabdomyosarcoma?
Wiener, E. S., Anderson, J. R., Ojimba, J. I., Lobe, T. E., Paidas, C., & Grier, H. E. (2001). Controversies in the management of paratesticular rhabdomyosarcoma: is staging retroperitoneal lymph node dissection necessary for adolescents with resected paratesticular rhabdomyosarcoma?. Seminars in pediatric surgery, 10(3), 146-152.

Presurgical window of carboplatin and surgery and multidrug chemotherapy for the treatment of newly diagnosed metastatic or unresectable osteosarcoma: Pediatric Oncology Group trial
Ferguson, W. S., Harris, M. B., Goorin, A. M., Gebhardt, M. C., Link, M. P., & Grier, H. E. (2001). Presurgical window of carboplatin and surgery and multidrug chemotherapy for the treatment of newly diagnosed metastatic or unresectable osteosarcoma: Pediatric Oncology Group trial. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 23(6), 340-348.

What constitutes optimal therapy for patients with rhabdomyosarcoma of the female genital tract?
Arndt, C. As., Donaldson, S. S., Anderson, J. R., Andrassy, R. J., Laurie, F., & Crist, W. M. (2001). What constitutes optimal therapy for patients with rhabdomyosarcoma of the female genital tract?. CANCER, 91(12), 2454-2468.

Thyroid carcinoma after successful treatment of osteosarcoma: A report of three patients
Verneris, M., McDougall, I. R., Becton, D., & Link, M. P. (2001). Thyroid carcinoma after successful treatment of osteosarcoma: A report of three patients. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 23(5), 312-315.

Attitudes and practices among pediatric oncologists regarding end-of-life care: Results of the 1998 American Society of Clinical Oncology survey
Hilden, J. M., Emanuel, E. J., Fairclough, D. L., Link, M. P., Foley, K. M., & Mayer, R. J. (2001). Attitudes and practices among pediatric oncologists regarding end-of-life care: Results of the 1998 American Society of Clinical Oncology survey. JOURNAL OF CLINICAL ONCOLOGY, 19(1), 205-212.

New recurring cytogenetic abnormalities and association of blast cell karyotypes with prognosis in childhood T-cell acute lymphoblastic leukemia: a Pediatric Oncology Group report of 343 cases
Schneider, N. R., Carroll, A. J., Shuster, J. J., Pullen, D. J., Link, M. P., & Amylon, M. D. (2000). New recurring cytogenetic abnormalities and association of blast cell karyotypes with prognosis in childhood T-cell acute lymphoblastic leukemia: a Pediatric Oncology Group report of 343 cases. BLOOD, 96(7), 2543-2549.

Benefit of intensified therapy for patients with local or regional embryonal rhabdomyosarcoma: Results from the Intergroup Rhabdomyosarcoma Study IV
Baker, K. S., Anderson, J. R., Link, M. P., Grier, H. E., Qualman, S. J., & Crist, W. M. (2000). Benefit of intensified therapy for patients with local or regional embryonal rhabdomyosarcoma: Results from the Intergroup Rhabdomyosarcoma Study IV. JOURNAL OF CLINICAL ONCOLOGY, 18(12), 2427-2434.

Effects of cranial radiation in children with high risk T cell acute lymphoblastic leukemia: a Pediatric Oncology Group report
Laver, J. H., Barredo, J. C., Amylon, M., Schwenn, M., Kurtzberg, J., & Shuster, J. (2000). Effects of cranial radiation in children with high risk T cell acute lymphoblastic leukemia: a Pediatric Oncology Group report. LEUKEMIA, 14(3), 369-373.

Burkitt lymphoma is immunophenotypically different from Burkitt-like lymphoma in young persons
Hutchison, R. E., Finch, C., Kepner, J., Fuller, C., Bowman, P., & Murphy, S. B. (2000). Burkitt lymphoma is immunophenotypically different from Burkitt-like lymphoma in young persons. ANNALS OF ONCOLOGY, 11, 35-38.

Significance of commonly used prognostic factors differs for children with T cell acute lymphocytic leukemia (ALL), as compared to those with B-precursor ALL. A Pediatric Oncology Group (POG) study
Pullen, J., Shuster, J. J., Link, M., Borowitz, M., Amylon, M., & Camitta, B. (1999). Significance of commonly used prognostic factors differs for children with T cell acute lymphocytic leukemia (ALL), as compared to those with B-precursor ALL. A Pediatric Oncology Group (POG) study. LEUKEMIA, 13(11), 1696-1707.

Intensive high-dose asparaginase consolidation improves survival for pediatric patients with T cell acute lymphoblastic leukemia and advanced stage lymphoblastic lymphoma: a Pediatric Oncology Group study
Amylon, M. D., Shuster, J., Pullen, J., Berard, C., Link, M. P., & Murphy, S. B. (1999). Intensive high-dose asparaginase consolidation improves survival for pediatric patients with T cell acute lymphoblastic leukemia and advanced stage lymphoblastic lymphoma: a Pediatric Oncology Group study. LEUKEMIA, 13(3), 335-342.

Treatment of localized primary non-Hodgkin's lymphoma of bone in children: A Pediatric Oncology Group study
Suryanarayan, K., Shuster, J. J., Donaldson, S. S., Hutchison, R. E., Murphy, S. B., & Link, M. P. (1999). Treatment of localized primary non-Hodgkin's lymphoma of bone in children: A Pediatric Oncology Group study. JOURNAL OF CLINICAL ONCOLOGY, 17(2), 456-459.

Childhood acute lymphoblastic leukemia with the MLL-ENL fusion and t(11;19)(q23;p13.3) translocation
Rubnitz, J. E., Camitta, B. M., Mahmoud, H., Raimondi, S. C., Carroll, A. J., & Pui, C. H. (1999). Childhood acute lymphoblastic leukemia with the MLL-ENL fusion and t(11;19)(q23;p13.3) translocation. JOURNAL OF CLINICAL ONCOLOGY, 17(1), 191-196.

Acute lymphoblastic leukemia with the (8;14)(q24;q32) translocation and FAB L3 morphology associated with a E-precursor immunophenotype: the Pediatric Oncology Group experience
Navid, F., Mosijczuk, A. D., Head, D. R., Borowitz, M. J., Carroll, A. J., & Pullen, D. J. (1999). Acute lymphoblastic leukemia with the (8;14)(q24;q32) translocation and FAB L3 morphology associated with a E-precursor immunophenotype: the Pediatric Oncology Group experience. LEUKEMIA, 13(1), 135-141.

Treatment of metastatic osteosarcoma at diagnosis: A pediatric oncology group study
Harris, M. B., Gieser, P., Goorin, A. M., Ayala, A., Shochat, S. J., & Link, M. P. (1998). Treatment of metastatic osteosarcoma at diagnosis: A pediatric oncology group study. JOURNAL OF CLINICAL ONCOLOGY, 16(11), 3641-3648.

A multidisciplinary study investigating radiotherapy in Ewing's sarcoma: End results of POG #8346
Donaldson, S. S., Torrey, M., Link, M. P., GLICKSMAN, A., Gilula, L., & Shuster, J. J. (1998). A multidisciplinary study investigating radiotherapy in Ewing's sarcoma: End results of POG #8346. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 42(1), 125-135.

Randomized trial of r-metHu granulocyte colony-stimulating factor in an intensive treatment for T-cell leukemia and advanced-stage lymphoblastic lymphoma of childhood: A pediatric oncology group pilot study
Laver, J., Amylon, M., Desai, S., Link, M., Schwenn, M., & Shuster, J. (1998). Randomized trial of r-metHu granulocyte colony-stimulating factor in an intensive treatment for T-cell leukemia and advanced-stage lymphoblastic lymphoma of childhood: A pediatric oncology group pilot study. JOURNAL OF CLINICAL ONCOLOGY, 16(2), 522-526.

E2A-PBX1 chimeric transcript status at end of consolidation is not predictive of treatment outcome in childhood acute lymphoblastic leukemias with a t(1;19)(q23;p13): A pediatric oncology group study
Hunger, S. P., Fall, M. Z., Camitta, B. M., Carroll, A. J., Link, M. P., & Cleary, M. L. (1998). E2A-PBX1 chimeric transcript status at end of consolidation is not predictive of treatment outcome in childhood acute lymphoblastic leukemias with a t(1;19)(q23;p13): A pediatric oncology group study. BLOOD, 91(3), 1021-1028.

Fractionated cyclophosphamide and back to back high dose methotrexate and cytosine arabinoside improves outcome in patients with stage III high grade small non-cleaved cell lymphomas (SNCCL): A randomized trial of the Pediatric Oncology Group
Brecher, M. L., Schwenn, M. R., Coppes, M. J., Bowman, W. P., Link, M. P., & Murphy, S. B. (1997). Fractionated cyclophosphamide and back to back high dose methotrexate and cytosine arabinoside improves outcome in patients with stage III high grade small non-cleaved cell lymphomas (SNCCL): A randomized trial of the Pediatric Oncology Group. MEDICAL AND PEDIATRIC ONCOLOGY, 29(6), 526-533.

Treatment of children and young adults with early-stage non-Hodgkin's lymphoma
Link, M. P., Shuster, J. J., Donaldson, S. S., Berard, C. W., & Murphy, S. B. (1997). Treatment of children and young adults with early-stage non-Hodgkin's lymphoma. NEW ENGLAND JOURNAL OF MEDICINE, 337(18), 1259-1266.

Lack of ETV6 (TEL) gene rearrangements or p16(INK4A)/p15(INK4B) homozygous gene deletions in infant acute lymphoblastic leukemia
Maloney, K. W., Rubnitz, J. E., Cleary, M. L., Frankel, L. S., Hakami, N., & Hunger, S. P. (1997). Lack of ETV6 (TEL) gene rearrangements or p16(INK4A)/p15(INK4B) homozygous gene deletions in infant acute lymphoblastic leukemia. LEUKEMIA, 11(7), 979-983.

Altered expression of p53 and mdm-2 proteins at diagnosis is associated with early treatment failure in childhood acute lymphoblastic leukemia
Marks, D. I., Kurz, B. W., Link, M. P., Ng, E., Shuster, J. J., & Haines, D. S. (1997). Altered expression of p53 and mdm-2 proteins at diagnosis is associated with early treatment failure in childhood acute lymphoblastic leukemia. JOURNAL OF CLINICAL ONCOLOGY, 15(3), 1158-1162.

A feasibility, toxicity, and early response study of etoposide, ifosfamide, and vincristine for the treatment of children with rhabdomyosarcoma: A report from the intergroup rhabdomyosarcoma study (IRS) IV pilot study
Arndt, C., Tefft, M., Gehan, E., Anderson, J., Jenson, M., & Maurer, H. (1997). A feasibility, toxicity, and early response study of etoposide, ifosfamide, and vincristine for the treatment of children with rhabdomyosarcoma: A report from the intergroup rhabdomyosarcoma study (IRS) IV pilot study. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 19(2), 124-129.

Frequent and selective methylation of p15 and deletion of both p15 and p16 in T-cell acute lymphoblastic leukemia
Batova, A., Diccianni, M. B., Yu, J. C., Nobori, T., Link, M. P., & Yu, A. L. (1997). Frequent and selective methylation of p15 and deletion of both p15 and p16 in T-cell acute lymphoblastic leukemia. CANCER RESEARCH, 57(5), 832-836.

Case-control study suggests a favorable impact of TEL rearrangement in patients with B-lineage acute lymphoblastic leukemia treated with antimetabolite-based therapy: A pediatric oncology group study
Rubnitz, J. E., Shuster, J. J., Land, V. J., Link, M. P., Pullen, J., & Behm, F. G. (1997). Case-control study suggests a favorable impact of TEL rearrangement in patients with B-lineage acute lymphoblastic leukemia treated with antimetabolite-based therapy: A pediatric oncology group study. BLOOD, 89(4), 1143-1146.

Use of an anti-ALK antibody in the characterization of anaplastic large-cell lymphoma of childhood
Hutchison, R. E., Banki, K., Shuster, J. J., Barrett, D., Dieck, C., & Morris, S. W. (1997). Use of an anti-ALK antibody in the characterization of anaplastic large-cell lymphoma of childhood. ANNALS OF ONCOLOGY, 8, 37-42.

NCCN pediatric osteosarcoma practice guidelines. The National Comprehensive Cancer Network.
O'Reilly, R., Link, M., FLETCHER, B., Gebhardt, M., Krance, R., & Schwartz, C. (1996). NCCN pediatric osteosarcoma practice guidelines. The National Comprehensive Cancer Network. Oncology (Williston Park, N.Y.), 10(12), 1799-?.

Improved survival for children with B-cell acute lymphoblastic leukemia and stage IV small noncleaved-cell lymphoma: A pediatric oncology group study
Bowman, W. P., Shuster, J. J., Cook, B., Griffin, T., Behm, F., & Murphy, S. (1996). Improved survival for children with B-cell acute lymphoblastic leukemia and stage IV small noncleaved-cell lymphoma: A pediatric oncology group study. JOURNAL OF CLINICAL ONCOLOGY, 14(4), 1252-1261.

High incidence of potential p53 inactivation in poor outcome childhood acute lymphoblastic leukemia at diagnosis
Marks, D. I., Kurz, B. W., Link, M. P., Ng, E., Shuster, J. J., & Haines, D. S. (1996). High incidence of potential p53 inactivation in poor outcome childhood acute lymphoblastic leukemia at diagnosis. BLOOD, 87(3), 1155-1161.

Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia
Smith, M., Arthur, D., Camitta, B., Carroll, A. J., Crist, W., & Ungerleider, R. (1996). Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia. JOURNAL OF CLINICAL ONCOLOGY, 14(1), 18-24.

STAGE-SPECIFIC AND LINEAGE-SPECIFIC EXPRESSION OF THE HOXA10 HOMEOBOX GENE IN NORMAL AND LEUKEMIC HEMATOPOIETIC-CELLS
Lawrence, H. J., Sauvageau, G., Ahmadi, N., LOPEZ, A. R., LEBEAU, M. M., & Largman, C. (1995). STAGE-SPECIFIC AND LINEAGE-SPECIFIC EXPRESSION OF THE HOXA10 HOMEOBOX GENE IN NORMAL AND LEUKEMIC HEMATOPOIETIC-CELLS. EXPERIMENTAL HEMATOLOGY, 23(11), 1160-1166.

B-CELL LINEAGE CONFERS A FAVORABLE OUTCOME AMONG CHILDREN AND ADOLESCENTS WITH LARGE-CELL LYMPHOMA - A PEDIATRIC-ONCOLOGY-GROUP STUDY
Hutchison, R. E., Berard, C. W., Shuster, J. J., Link, M. P., Pick, T. E., & Murphy, S. B. (1995). B-CELL LINEAGE CONFERS A FAVORABLE OUTCOME AMONG CHILDREN AND ADOLESCENTS WITH LARGE-CELL LYMPHOMA - A PEDIATRIC-ONCOLOGY-GROUP STUDY. JOURNAL OF CLINICAL ONCOLOGY, 13(8), 2023-2032.

SAFETY AND EFFICACY OF L-LEUCOVORIN RESCUE FOLLOWING HIGH-DOSE METHOTREXATE FOR OSTEOSARCOMA
Goorin, A., Strother, D., Poplack, D., LETVAK, L. A., George, M., & Link, M. (1995). SAFETY AND EFFICACY OF L-LEUCOVORIN RESCUE FOLLOWING HIGH-DOSE METHOTREXATE FOR OSTEOSARCOMA. MEDICAL AND PEDIATRIC ONCOLOGY, 24(6), 362-367.

TREATMENT OF OSTEOSARCOMA WITH IFOSFAMIDE - COMPARISON OF RESPONSE IN PEDIATRIC-PATIENTS WITH RECURRENT DISEASE VERSUS PATIENTS PREVIOUSLY UNTREATED - A PEDIATRIC-ONCOLOGY-GROUP STUDY
Harris, M. B., Cantor, A. B., Goorin, A. M., Shochat, S. J., AYALA, A. G., & Link, M. P. (1995). TREATMENT OF OSTEOSARCOMA WITH IFOSFAMIDE - COMPARISON OF RESPONSE IN PEDIATRIC-PATIENTS WITH RECURRENT DISEASE VERSUS PATIENTS PREVIOUSLY UNTREATED - A PEDIATRIC-ONCOLOGY-GROUP STUDY. MEDICAL AND PEDIATRIC ONCOLOGY, 24(2), 87-92.

ABVD/MOPP AND LOW-DOSE INVOLVED-FIELD RADIOTHERAPY IN PEDIATRIC HODGKINS-DISEASE - THE STANFORD EXPERIENCE
Hunger, S. P., Link, M. P., & Donaldson, S. S. (1994). ABVD/MOPP AND LOW-DOSE INVOLVED-FIELD RADIOTHERAPY IN PEDIATRIC HODGKINS-DISEASE - THE STANFORD EXPERIENCE. JOURNAL OF CLINICAL ONCOLOGY, 12(10), 2160-2166.

HYPNOSIS IN THE PREVENTION OF CHEMOTHERAPY-RELATED NAUSEA AND VOMITING IN CHILDREN - A PROSPECTIVE-STUDY
JACKNOW, D. S., Tschann, J. M., Link, M. P., & Boyce, W. T. (1994). HYPNOSIS IN THE PREVENTION OF CHEMOTHERAPY-RELATED NAUSEA AND VOMITING IN CHILDREN - A PROSPECTIVE-STUDY. JOURNAL OF DEVELOPMENTAL AND BEHAVIORAL PEDIATRICS, 15(4), 258-264.

FREQUENCY AND PROGNOSTIC-SIGNIFICANCE OF HRX REARRANGEMENTS IN INFANT ACUTE LYMPHOBLASTIC-LEUKEMIA - A PEDIATRIC-ONCOLOGY-GROUP STUDY
Rubnitz, J. E., Link, M. P., Shuster, J. J., Carroll, A. J., Hakami, N., & Cleary, M. L. (1994). FREQUENCY AND PROGNOSTIC-SIGNIFICANCE OF HRX REARRANGEMENTS IN INFANT ACUTE LYMPHOBLASTIC-LEUKEMIA - A PEDIATRIC-ONCOLOGY-GROUP STUDY. BLOOD, 84(2), 570-573.

SIMULTANEOUS EXPRESSION OF RBTN-2 AND BCR-ABL ONCOGENES IN A T-ALL WITH A T(1114)(P13Q11) AND A LATE-APPEARING PHILADELPHIA-CHROMOSOME
Fizzotti, M., CHEN, E. Y., Link, M. P., Carroll, A. J., Foroni, L., & Clark, S. S. (1994). SIMULTANEOUS EXPRESSION OF RBTN-2 AND BCR-ABL ONCOGENES IN A T-ALL WITH A T(1114)(P13Q11) AND A LATE-APPEARING PHILADELPHIA-CHROMOSOME. LEUKEMIA, 8(7), 1124-1130.

PRESENTING CHARACTERISTICS OF TRISOMY-8 AS THE PRIMARY CYTOGENETIC ABNORMALITY ASSOCIATED WITH CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA - A PEDIATRIC-ONCOLOGY-GROUP (POG) STUDY-(8600/8493)
Pettenati, M. J., Rao, N., Wofford, M., Shuster, J. J., Pullen, D. J., & Carroll, A. J. (1994). PRESENTING CHARACTERISTICS OF TRISOMY-8 AS THE PRIMARY CYTOGENETIC ABNORMALITY ASSOCIATED WITH CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA - A PEDIATRIC-ONCOLOGY-GROUP (POG) STUDY-(8600/8493). CANCER GENETICS AND CYTOGENETICS, 75(1), 6-10.

MIC2 ANALYSIS IN PEDIATRIC LYMPHOMAS AND LEUKEMIAS
Riopel, M., Dickman, P. S., Link, M. P., & Perlman, E. J. (1994). MIC2 ANALYSIS IN PEDIATRIC LYMPHOMAS AND LEUKEMIAS. HUMAN PATHOLOGY, 25(4), 396-399.

EWINGS-SARCOMA - ROUTINE DIAGNOSTIC UTILIZATION OF MIC2 ANALYSIS - A PEDIATRIC-ONCOLOGY-GROUP CHILDRENS-CANCER-GROUP INTERGROUP STUDY
Perlman, E. J., Dickman, P. S., Askin, F. B., Grier, H. E., Miser, J. S., & Link, M. P. (1994). EWINGS-SARCOMA - ROUTINE DIAGNOSTIC UTILIZATION OF MIC2 ANALYSIS - A PEDIATRIC-ONCOLOGY-GROUP CHILDRENS-CANCER-GROUP INTERGROUP STUDY. HUMAN PATHOLOGY, 25(3), 304-307.

SECONDARY BREAST-CANCER IN PATIENTS PRESENTING WITH OSTEOSARCOMA - POSSIBLE INVOLVEMENT OF GERMLINE P53 MUTATIONS
Russo, C. L., McIntyre, J., Goorin, A. M., Link, M. P., Gebhardt, M. C., & Friend, S. H. (1994). SECONDARY BREAST-CANCER IN PATIENTS PRESENTING WITH OSTEOSARCOMA - POSSIBLE INVOLVEMENT OF GERMLINE P53 MUTATIONS. MEDICAL AND PEDIATRIC ONCOLOGY, 23(4), 354-358.

HODGKINS-DISEASE IN THE VERY YOUNG
Cleary, S. F., Link, M. P., & Donaldson, S. S. (1994). HODGKINS-DISEASE IN THE VERY YOUNG. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 28(1), 77-83.

IMMUNOCYTOCHEMICAL STUDY OF 12E7 IN SMALL ROUND-CELL TUMORS OF CHILDHOOD - AN ASSESSMENT OF ITS SENSITIVITY AND SPECIFICITY
Ramani, P., Rampling, D., & Link, M. (1993). IMMUNOCYTOCHEMICAL STUDY OF 12E7 IN SMALL ROUND-CELL TUMORS OF CHILDHOOD - AN ASSESSMENT OF ITS SENSITIVITY AND SPECIFICITY. HISTOPATHOLOGY, 23(6), 557-561.

DETECTION OF THE (11 22)(Q24 Q12) TRANSLOCATION OF EWINGS-SARCOMA AND PERIPHERAL NEUROECTODERMAL TUMOR BY REVERSE TRANSCRIPTION-POLYMERASE CHAIN-REACTION
Downing, J. R., Head, D. R., Parham, D. M., Douglass, E. C., HULSHOF, M. G., & Shapiro, D. N. (1993). DETECTION OF THE (11 22)(Q24 Q12) TRANSLOCATION OF EWINGS-SARCOMA AND PERIPHERAL NEUROECTODERMAL TUMOR BY REVERSE TRANSCRIPTION-POLYMERASE CHAIN-REACTION. AMERICAN JOURNAL OF PATHOLOGY, 143(5), 1294-1300.

HRX INVOLVEMENT IN DENOVO AND SECONDARY LEUKEMIAS WITH DIVERSE CHROMOSOME 11Q23 ABNORMALITIES
Hunger, S. P., Tkachuk, D. C., Amylon, M. D., Link, M. P., Carroll, A. J., & Cleary, M. L. (1993). HRX INVOLVEMENT IN DENOVO AND SECONDARY LEUKEMIAS WITH DIVERSE CHROMOSOME 11Q23 ABNORMALITIES. BLOOD, 81(12), 3197-3203.

ACUTE HYPERSENSITIVITY REACTIONS TO ETOPOSIDE IN A VEPA REGIMEN FOR HODGKINS-DISEASE
Hudson, M. M., Weinstein, H. J., Donaldson, S. S., Greenwald, C., Kun, L., & Link, M. P. (1993). ACUTE HYPERSENSITIVITY REACTIONS TO ETOPOSIDE IN A VEPA REGIMEN FOR HODGKINS-DISEASE. JOURNAL OF CLINICAL ONCOLOGY, 11(6), 1080-1084.

LABORATORY CLINICAL INTERFACE
Link, M. P., Stevens, J., Friend, S. H., Israel, M. A., Knudson, A. G., & Sondel, P. M. (1993). LABORATORY CLINICAL INTERFACE. CANCER, 71(10), 3219-3221.

CLINICAL-FEATURES AND OUTCOME OF T-CELL ACUTE LYMPHOBLASTIC-LEUKEMIA IN CHILDHOOD WITH RESPECT TO ALTERATIONS AT THE TAL1 LOCUS - A PEDIATRIC ONCOLOGY GROUP-STUDY
Bash, R. O., Crist, W. M., Shuster, J. J., Link, M. P., Amylon, M., & Baer, R. (1993). CLINICAL-FEATURES AND OUTCOME OF T-CELL ACUTE LYMPHOBLASTIC-LEUKEMIA IN CHILDHOOD WITH RESPECT TO ALTERATIONS AT THE TAL1 LOCUS - A PEDIATRIC ONCOLOGY GROUP-STUDY. BLOOD, 81(8), 2110-2117.

A SERINE PROLINE-RICH PROTEIN IS FUSED TO HRX IN T(4-11) ACUTE LEUKEMIAS
Morrissey, J., Tkachuk, D. C., MILATOVICH, A., FRANCKE, U., Link, M., & Cleary, M. L. (1993). A SERINE PROLINE-RICH PROTEIN IS FUSED TO HRX IN T(4-11) ACUTE LEUKEMIAS. BLOOD, 81(5), 1124-1131.

The multi-institutional osteosarcoma study: an update.
Link, M. P. (1993). The multi-institutional osteosarcoma study: an update. Cancer treatment and research, 62, 261-267.

LANGERHANS CELL HISTIOCYTOSIS PRESENTING WITH THE SUPERIOR VENA-CAVA SYNDROME - A CASE-REPORT
Mogul, M., HARTMAN, G., Donaldson, S., Gelb, A., Link, M., & Glader, B. (1993). LANGERHANS CELL HISTIOCYTOSIS PRESENTING WITH THE SUPERIOR VENA-CAVA SYNDROME - A CASE-REPORT. MEDICAL AND PEDIATRIC ONCOLOGY, 21(6), 456-459.

Osteosarcoma in adolescents and young adults: new developments and controversies. Commentary on the use of presurgical chemotherapy.
Link, M. P. (1993). Osteosarcoma in adolescents and young adults: new developments and controversies. Commentary on the use of presurgical chemotherapy. Cancer treatment and research, 62, 383-385.

A STUDY OF TOXICITY AND COMPARATIVE THERAPEUTIC EFFICACY OF VINDESINE-PREDNISONE VS VINCRISTINE-PREDNISONE IN CHILDREN WITH ACUTE LYMPHOBLASTIC-LEUKEMIA IN RELAPSE - A PEDIATRIC ONCOLOGY GROUP-STUDY
Vats, T., Buchanan, G., Mehta, P., Ragab, A., HVIZDALE, E., & Krischer, J. (1992). A STUDY OF TOXICITY AND COMPARATIVE THERAPEUTIC EFFICACY OF VINDESINE-PREDNISONE VS VINCRISTINE-PREDNISONE IN CHILDREN WITH ACUTE LYMPHOBLASTIC-LEUKEMIA IN RELAPSE - A PEDIATRIC ONCOLOGY GROUP-STUDY. INVESTIGATIONAL NEW DRUGS, 10(3), 231-234.

CHILDHOOD MALIGNANT NON-HODGKIN LYMPHOMAS OF UNCOMMON HISTOLOGY
Ribeiro, R. C., Pui, C. H., Murphy, S. B., Shuster, J. J., HVIZDALA, E. V., & Berard, C. W. (1992). CHILDHOOD MALIGNANT NON-HODGKIN LYMPHOMAS OF UNCOMMON HISTOLOGY. LEUKEMIA, 6(8), 761-765.

MORPHOLOGICAL, IMMUNOLOGICAL AND CYTOGENETIC STUDIES IN CHILDREN WITH ACUTE LYMPHOBLASTIC-LEUKEMIA AT DIAGNOSIS AND RELAPSE - A PEDIATRIC ONCOLOGY GROUP-STUDY
Abshire, T. C., Buchanan, G. R., Jackson, J. F., Shuster, J. J., Brock, B., & Pullen, D. J. (1992). MORPHOLOGICAL, IMMUNOLOGICAL AND CYTOGENETIC STUDIES IN CHILDREN WITH ACUTE LYMPHOBLASTIC-LEUKEMIA AT DIAGNOSIS AND RELAPSE - A PEDIATRIC ONCOLOGY GROUP-STUDY. LEUKEMIA, 6(5), 357-362.

ISOCHROMOSOMES IN CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA - A COLLABORATIVE STUDY OF 83 CASES
Pui, C. H., Carroll, A. J., Raimondi, S. C., Schell, M. J., Head, D. R., & Land, V. J. (1992). ISOCHROMOSOMES IN CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA - A COLLABORATIVE STUDY OF 83 CASES. BLOOD, 79(9), 2384-2391.

PROGRESS AGAINST CHILDHOOD-CANCER - THE PEDIATRIC ONCOLOGY GROUP EXPERIENCE
Vietti, T. J., Land, V., Shuster, J. J., Amylon, M., Link, M., & Wharam, M. (1992). PROGRESS AGAINST CHILDHOOD-CANCER - THE PEDIATRIC ONCOLOGY GROUP EXPERIENCE. PEDIATRICS, 89(4), 597-600.

INTENSIVE SEQUENTIAL CHEMOTHERAPY FOR CHILDREN WITH ACUTE MYELOGENOUS LEUKEMIA - VAPA, 80-035, AND HI-C-DAZE
Grier, H. E., Gelber, R. D., Link, M. P., CAMITTA, B. P., Clavell, L. A., & WEISTEIN, H. J. (1992). INTENSIVE SEQUENTIAL CHEMOTHERAPY FOR CHILDREN WITH ACUTE MYELOGENOUS LEUKEMIA - VAPA, 80-035, AND HI-C-DAZE. LEUKEMIA, 6, 48-51.

T(2-14)(P13-Q32) - A RECURRING ABNORMALITY IN LYMPHOCYTIC-LEUKEMIA - A PEDIATRIC-ONCOLOGY-GROUP STUDY
Watson, M. S., Land, V. J., Carroll, A. J., Pullen, J., Borowitz, M. J., & Behm, F. G. (1992). T(2-14)(P13-Q32) - A RECURRING ABNORMALITY IN LYMPHOCYTIC-LEUKEMIA - A PEDIATRIC-ONCOLOGY-GROUP STUDY. CANCER GENETICS AND CYTOGENETICS, 58(2), 121-124.

Current results of studies of immunophenotype-, age- and leukocyte-based therapy for children with acute lymphoblastic leukemia. The Pediatric Oncology Group.
Crist, W., Shuster, J., Look, T., Borowitz, M., Behm, F., & Steuber, P. (1992). Current results of studies of immunophenotype-, age- and leukocyte-based therapy for children with acute lymphoblastic leukemia. The Pediatric Oncology Group. Leukemia , 6, 162-166.

ACUTE LYMPHOBLASTIC-LEUKEMIA OCCURRING AS A 2ND MALIGNANT NEOPLASM IN CHILDHOOD - REPORT OF 3 CASES AND REVIEW OF THE LITERATURE
Hunger, S. P., Sklar, J., & Link, M. P. (1992). ACUTE LYMPHOBLASTIC-LEUKEMIA OCCURRING AS A 2ND MALIGNANT NEOPLASM IN CHILDHOOD - REPORT OF 3 CASES AND REVIEW OF THE LITERATURE. JOURNAL OF CLINICAL ONCOLOGY, 10(1), 156-163.

OSTEOSARCOMA - GOOD-NEWS DESPITE CRUDE TOOLS
Simone, J. V., Meyer, W. H., & Link, M. P. (1992). OSTEOSARCOMA - GOOD-NEWS DESPITE CRUDE TOOLS. JOURNAL OF CLINICAL ONCOLOGY, 10(1), 1-2.

ADJUVANT CHEMOTHERAPY OF HIGH-GRADE OSTEOSARCOMA OF THE EXTREMITY - UPDATED RESULTS OF THE MULTIINSTITUTIONAL OSTEOSARCOMA STUDY
Link, M. P., Goorin, A. M., Horowitz, M., Meyer, W. H., Belasco, J., & Shuster, J. (1991). ADJUVANT CHEMOTHERAPY OF HIGH-GRADE OSTEOSARCOMA OF THE EXTREMITY - UPDATED RESULTS OF THE MULTIINSTITUTIONAL OSTEOSARCOMA STUDY. CLINICAL ORTHOPAEDICS AND RELATED RESEARCH, (270), 8-14.

NITROGEN-MUSTARD, VINCRISTINE, PROCARBAZINE, AND PREDNISONE AS ADJUVANT CHEMOTHERAPY IN THE TREATMENT OF MEDULLOBLASTOMA - A PEDIATRIC ONCOLOGY GROUP-STUDY
Krischer, J. P., Ragab, A. H., Kun, L., Kim, T. H., Laurent, J. P., & Camitta, B. (1991). NITROGEN-MUSTARD, VINCRISTINE, PROCARBAZINE, AND PREDNISONE AS ADJUVANT CHEMOTHERAPY IN THE TREATMENT OF MEDULLOBLASTOMA - A PEDIATRIC ONCOLOGY GROUP-STUDY. JOURNAL OF NEUROSURGERY, 74(6), 905-909.

HODGKINS-DISEASE - TREATMENT OF THE YOUNG-CHILD
Donaldson, S. S., & Link, M. P. (1991). HODGKINS-DISEASE - TREATMENT OF THE YOUNG-CHILD. PEDIATRIC CLINICS OF NORTH AMERICA, 38(2), 457-473.

CHANGING PATTERN OF PULMONARY METASTASES WITH ADJUVANT CHEMOTHERAPY IN PATIENTS WITH OSTEOSARCOMA - RESULTS FROM THE MULTIINSTITUTIONAL OSTEOSARCOMA STUDY
Goorin, A. M., Shuster, J. J., Baker, A., Horowitz, M. E., Meyer, W. H., & Link, M. P. (1991). CHANGING PATTERN OF PULMONARY METASTASES WITH ADJUVANT CHEMOTHERAPY IN PATIENTS WITH OSTEOSARCOMA - RESULTS FROM THE MULTIINSTITUTIONAL OSTEOSARCOMA STUDY. JOURNAL OF CLINICAL ONCOLOGY, 9(4), 600-605.

PHILADELPHIA-CHROMOSOME AND MONOSOMY-7 IN CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA - A PEDIATRIC ONCOLOGY GROUP-STUDY
Russo, C., Carroll, A., Kohler, S., Borowitz, M., Amylon, M., & Link, M. (1991). PHILADELPHIA-CHROMOSOME AND MONOSOMY-7 IN CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA - A PEDIATRIC ONCOLOGY GROUP-STUDY. BLOOD, 77(5), 1050-1056.

THE T(1-19)(Q23-P13) RESULTS IN CONSISTENT FUSION OF E2A AND PBX1 CODING SEQUENCES IN ACUTE LYMPHOBLASTIC LEUKEMIAS
Hunger, S. P., Galili, N., Carroll, A. J., Crist, W. M., Link, M. P., & Cleary, M. L. (1991). THE T(1-19)(Q23-P13) RESULTS IN CONSISTENT FUSION OF E2A AND PBX1 CODING SEQUENCES IN ACUTE LYMPHOBLASTIC LEUKEMIAS. BLOOD, 77(4), 687-693.

LACK OF TRANSMISSION OF THE LIVE ATTENUATED VARICELLA VACCINE VIRUS TO IMMUNOCOMPROMISED CHILDREN AFTER IMMUNIZATION OF THEIR SIBLINGS
Diaz, P. S., Au, D., Smith, S., Amylon, M., Link, M., & Arvin, A. M. (1991). LACK OF TRANSMISSION OF THE LIVE ATTENUATED VARICELLA VACCINE VIRUS TO IMMUNOCOMPROMISED CHILDREN AFTER IMMUNIZATION OF THEIR SIBLINGS. PEDIATRICS, 87(2), 166-170.

CONSISTENT INVOLVEMENT OF THE BCR GENE BY 9-22 BREAKPOINTS IN PEDIATRIC ACUTE LEUKEMIAS
Suryanarayan, K., Hunger, S. P., Kohler, S., Carroll, A. J., Crist, W., & Cleary, M. L. (1991). CONSISTENT INVOLVEMENT OF THE BCR GENE BY 9-22 BREAKPOINTS IN PEDIATRIC ACUTE LEUKEMIAS. BLOOD, 77(2), 324-330.

DOWN-REGULATED C-MYB EXPRESSION INHIBITS DNA-SYNTHESIS OF T-LEUKEMIA CELLS IN MOST PATIENTS
Venturelli, D., MARIANO, M. T., Szczylik, C., Valtieri, M., Lange, B., & Calabretta, B. (1990). DOWN-REGULATED C-MYB EXPRESSION INHIBITS DNA-SYNTHESIS OF T-LEUKEMIA CELLS IN MOST PATIENTS. CANCER RESEARCH, 50(22), 7371-7375.

THE T(1-14)(P34-Q11) IS NONRANDOM AND RESTRICTED TO T-CELL ACUTE LYMPHOBLASTIC-LEUKEMIA - A PEDIATRIC ONCOLOGY GROUP-STUDY
Carroll, A. J., Crist, W. M., Link, M. P., Amylon, M. D., Pullen, D. J., & Vietti, T. J. (1990). THE T(1-14)(P34-Q11) IS NONRANDOM AND RESTRICTED TO T-CELL ACUTE LYMPHOBLASTIC-LEUKEMIA - A PEDIATRIC ONCOLOGY GROUP-STUDY. BLOOD, 76(6), 1220-1224.

PHILADELPHIA-CHROMOSOME POSITIVE CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA - CLINICAL AND CYTOGENETIC CHARACTERISTICS AND TREATMENT OUTCOME - A PEDIATRIC-ONCOLOGY-GROUP STUDY
Crist, W., Carroll, A., Shuster, J., Jackson, J., Head, D., & Pullen, J. (1990). PHILADELPHIA-CHROMOSOME POSITIVE CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA - CLINICAL AND CYTOGENETIC CHARACTERISTICS AND TREATMENT OUTCOME - A PEDIATRIC-ONCOLOGY-GROUP STUDY. BLOOD, 76(3), 489-494.

NEAR-TRIPLOID AND NEAR-TETRAPLOID ACUTE LYMPHOBLASTIC-LEUKEMIA OF CHILDHOOD
Pui, C. H., Carroll, A. J., Head, D., Raimondi, S. C., Shuster, J. J., & Look, A. T. (1990). NEAR-TRIPLOID AND NEAR-TETRAPLOID ACUTE LYMPHOBLASTIC-LEUKEMIA OF CHILDHOOD. BLOOD, 76(3), 590-596.

STAGE-I-II PEDIATRIC HODGKINS-DISEASE - LONG-TERM FOLLOW-UP DEMONSTRATES EQUIVALENT SURVIVAL RATES FOLLOWING DIFFERENT MANAGEMENT SCHEMES
Donaldson, S. S., Whitaker, S. J., Plowman, P. N., Link, M. P., & Malpas, J. S. (1990). STAGE-I-II PEDIATRIC HODGKINS-DISEASE - LONG-TERM FOLLOW-UP DEMONSTRATES EQUIVALENT SURVIVAL RATES FOLLOWING DIFFERENT MANAGEMENT SCHEMES. JOURNAL OF CLINICAL ONCOLOGY, 8(7), 1128-1137.

RESULTS OF TREATMENT OF CHILDHOOD LOCALIZED NON-HODGKINS-LYMPHOMA WITH COMBINATION CHEMOTHERAPY WITH OR WITHOUT RADIOTHERAPY
Link, M. P., Donaldson, S. S., Berard, C. W., Shuster, J. J., & Murphy, S. B. (1990). RESULTS OF TREATMENT OF CHILDHOOD LOCALIZED NON-HODGKINS-LYMPHOMA WITH COMBINATION CHEMOTHERAPY WITH OR WITHOUT RADIOTHERAPY. NEW ENGLAND JOURNAL OF MEDICINE, 322(17), 1169-1174.

Intensive sequential chemotherapy for children with acute myelogenous leukemia.
Grier, H. E., Gelber, R. D., Clavell, L. A., Camitta, B. M., Link, M. P., & Weinstein, H. J. (1990). Intensive sequential chemotherapy for children with acute myelogenous leukemia. Haematology and blood transfusion, 33, 193-197.

SMALL CELL OSTEO-SARCOMA - A CLINICOPATHOLOGIC STUDY OF 27 CASES
AYALA, A. G., Ro, J. Y., Raymond, A. K., Jaffe, N., Chawla, S., & Benjamin, R. (1989). SMALL CELL OSTEO-SARCOMA - A CLINICOPATHOLOGIC STUDY OF 27 CASES. CANCER, 64(10), 2162-2173.

AGGRESSIVE MANAGEMENT OF 2ND PRIMARY TUMORS IN SURVIVORS OF HEREDITARY RETINOBLASTOMA
Smith, L. M., Donaldson, S. S., Egbert, P. R., Link, M. P., & Bagshaw, M. A. (1989). AGGRESSIVE MANAGEMENT OF 2ND PRIMARY TUMORS IN SURVIVORS OF HEREDITARY RETINOBLASTOMA. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 17(3), 499-505.

ABSENCE OF IG-V REGION GENE SOMATIC HYPERMUTATION IN ADVANCED BURKITTS-LYMPHOMA
Carroll, W. L., Yu, M., Link, M. P., & Korsmeyer, S. J. (1989). ABSENCE OF IG-V REGION GENE SOMATIC HYPERMUTATION IN ADVANCED BURKITTS-LYMPHOMA. JOURNAL OF IMMUNOLOGY, 143(2), 692-698.

DIFFUSE SMALL NONCLEAVED CELL LYMPHOMA IN CHILDREN, BURKITT VERSUS NON-BURKITT TYPES - RESULTS FROM THE PEDIATRIC ONCOLOGY GROUP AND ST-JUDE-CHILDRENS-RESEARCH-HOSPITAL
Hutchison, R. E., Murphy, S. B., Fairclough, D. L., Shuster, J. J., Sullivan, M. P., & Berard, C. W. (1989). DIFFUSE SMALL NONCLEAVED CELL LYMPHOMA IN CHILDREN, BURKITT VERSUS NON-BURKITT TYPES - RESULTS FROM THE PEDIATRIC ONCOLOGY GROUP AND ST-JUDE-CHILDRENS-RESEARCH-HOSPITAL. CANCER, 64(1), 23-27.

LONG-TERM GROWTH OF MALIGNANT THYMOCYTES INVITRO
Smith, S. D., McFall, P., Morgan, R., Link, M., Hecht, F., & Sklar, J. (1989). LONG-TERM GROWTH OF MALIGNANT THYMOCYTES INVITRO. BLOOD, 73(8), 2182-2187.

CYTO-TOXIC LYMPHOCYTE-T SPECIFIC FOR SELF TUMOR IMMUNOGLOBULIN EXPRESS T-CELL RECEPTOR DELTA-CHAIN
Wright, A., Lee, J. E., Link, M. P., Smith, S. D., Carroll, W., & KRENSKY, A. M. (1989). CYTO-TOXIC LYMPHOCYTE-T SPECIFIC FOR SELF TUMOR IMMUNOGLOBULIN EXPRESS T-CELL RECEPTOR DELTA-CHAIN. JOURNAL OF EXPERIMENTAL MEDICINE, 169(5), 1557-1564.

PEDIATRIC HODGKINS-DISEASE - PULMONARY, CARDIAC, AND THYROID-FUNCTION FOLLOWING COMBINED MODALITY THERAPY
MEFFERD, J. M., Donaldson, S. S., & Link, M. P. (1989). PEDIATRIC HODGKINS-DISEASE - PULMONARY, CARDIAC, AND THYROID-FUNCTION FOLLOWING COMBINED MODALITY THERAPY. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 16(3), 679-685.

CEREBELLAR ATROPHY CAUSED BY HIGH-DOSE CYTOSINE-ARABINOSIDE - CT AND MR FINDINGS
Miller, L., Link, M. P., Bologna, S., & Parker, B. R. (1989). CEREBELLAR ATROPHY CAUSED BY HIGH-DOSE CYTOSINE-ARABINOSIDE - CT AND MR FINDINGS. AMERICAN JOURNAL OF ROENTGENOLOGY, 152(2), 343-344.

Clinical investigations of children with Hodgkin's disease at Stanford University Medical Center. A preliminary overview using low-dose irradiation and alternating ABVD/MOPP chemotherapy.
Donaldson, S. S., Link, M. P., McDougall, I. R., Parker, B. R., & Shochat, S. J. (1989). Clinical investigations of children with Hodgkin's disease at Stanford University Medical Center. A preliminary overview using low-dose irradiation and alternating ABVD/MOPP chemotherapy. Cancer treatment and research, 41, 307-315.

POOR-RISK NON-LYMPHOBLASTIC LYMPHOMA OF CHILDHOOD - RESULTS OF AN INTENSIVE PILOT-STUDY
Finlay, J. L., Trigg, M. E., Link, M. P., & Frierdich, S. (1989). POOR-RISK NON-LYMPHOBLASTIC LYMPHOMA OF CHILDHOOD - RESULTS OF AN INTENSIVE PILOT-STUDY. MEDICAL AND PEDIATRIC ONCOLOGY, 17(1), 29-38.

CONTINUING REARRANGEMENT BUT ABSENCE OF SOMATIC HYPERMUTATION IN IMMUNOGLOBULIN GENES OF HUMAN B-CELL PRECURSOR LEUKEMIA
Bird, J., Galili, N., Link, M., Stites, D., & Sklar, J. (1988). CONTINUING REARRANGEMENT BUT ABSENCE OF SOMATIC HYPERMUTATION IN IMMUNOGLOBULIN GENES OF HUMAN B-CELL PRECURSOR LEUKEMIA. JOURNAL OF EXPERIMENTAL MEDICINE, 168(1), 229-245.

TREATMENT OF OSTEO-SARCOMA
Link, M. P. (1988). TREATMENT OF OSTEO-SARCOMA. LANCET, 1(8598), 1334-1334.

PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC-LEUKEMIA CELL-LINES WITHOUT CLASSICAL BREAKPOINT CLUSTER REGION REARRANGEMENT
Naumovski, L., Morgan, R., Hecht, F., Link, M. P., Glader, B. E., & Smith, S. D. (1988). PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC-LEUKEMIA CELL-LINES WITHOUT CLASSICAL BREAKPOINT CLUSTER REGION REARRANGEMENT. CANCER RESEARCH, 48(10), 2876-2879.

IDIOTYPE AS A TUMOR-SPECIFIC MARKER IN CHILDHOOD B-CELL ACUTE LYMPHOBLASTIC-LEUKEMIA
Carroll, W. L., Link, M. P., Cleary, M. L., Bologna, S., CARSWELL, C., & Levy, R. (1988). IDIOTYPE AS A TUMOR-SPECIFIC MARKER IN CHILDHOOD B-CELL ACUTE LYMPHOBLASTIC-LEUKEMIA. BLOOD, 71(4), 1068-1073.

CLINICAL AND BIOLOGIC CHARACTERIZATION OF T-CELL NEOPLASIAS WITH REARRANGEMENTS OF CHROMOSOME-7 BAND Q34
Smith, S. D., Morgan, R., Gemmell, R., Amylon, M. D., Link, M. P., & Hecht, F. (1988). CLINICAL AND BIOLOGIC CHARACTERIZATION OF T-CELL NEOPLASIAS WITH REARRANGEMENTS OF CHROMOSOME-7 BAND Q34. BLOOD, 71(2), 395-402.

ABSENCE OF CELL-SURFACE LFA-1 AS A MECHANISM OF ESCAPE FROM IMMUNOSURVEILLANCE
CLAYBERGER, C., Medeiros, L. J., Link, M. P., Warnke, R. A., Wright, A., & KRENSKY, A. M. (1987). ABSENCE OF CELL-SURFACE LFA-1 AS A MECHANISM OF ESCAPE FROM IMMUNOSURVEILLANCE. LANCET, 2(8558), 533-536.

WEEKLY HIGH-DOSE METHOTREXATE AND DOXORUBICIN FOR OSTEOSARCOMA - THE DANA-FARBER-CANCER-INSTITUTE THE CHILDRENS-HOSPITAL - STUDY-III
Goorin, A. M., PEREZATAYDE, A., Gebhardt, M., Andersen, J. W., Wilkinson, R. H., & Abelson, H. T. (1987). WEEKLY HIGH-DOSE METHOTREXATE AND DOXORUBICIN FOR OSTEOSARCOMA - THE DANA-FARBER-CANCER-INSTITUTE THE CHILDRENS-HOSPITAL - STUDY-III. JOURNAL OF CLINICAL ONCOLOGY, 5(8), 1178-1184.

PROGNOSTIC FACTORS IN CHILDHOOD ACUTE MYELOGENOUS LEUKEMIA
Grier, H. E., Gelber, R. D., Camitta, B. M., DELOREY, M. J., Link, M. P., & Weinstein, H. J. (1987). PROGNOSTIC FACTORS IN CHILDHOOD ACUTE MYELOGENOUS LEUKEMIA. JOURNAL OF CLINICAL ONCOLOGY, 5(7), 1026-1032.

GIANT-CELL PNEUMONIA CAUSED BY PARA-INFLUENZA TYPE-3 IN A PATIENT WITH ACUTE MYELOMONOCYTIC LEUKEMIA
Weintrub, P. S., Sullender, W. M., Lombard, C., Link, M. P., & Arvin, A. (1987). GIANT-CELL PNEUMONIA CAUSED BY PARA-INFLUENZA TYPE-3 IN A PATIENT WITH ACUTE MYELOMONOCYTIC LEUKEMIA. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 111(6), 569-570.

COMBINED MODALITY TREATMENT WITH LOW-DOSE RADIATION AND MOPP CHEMOTHERAPY FOR CHILDREN WITH HODGKINS-DISEASE
Donaldson, S. S., & Link, M. P. (1987). COMBINED MODALITY TREATMENT WITH LOW-DOSE RADIATION AND MOPP CHEMOTHERAPY FOR CHILDREN WITH HODGKINS-DISEASE. JOURNAL OF CLINICAL ONCOLOGY, 5(5), 742-749.

IMPROVED RESULTS OF TREATMENT OF ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA
Linker, C. A., Levitt, L. J., ODONNELL, M., Ries, C. A., Link, M. P., & FARBSTEIN, M. J. (1987). IMPROVED RESULTS OF TREATMENT OF ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA. BLOOD, 69(4), 1242-1248.

QUANTITATION AND ESTIMATION OF LYMPHOCYTE SUBSETS IN TISSUE-SECTIONS - COMPARISON WITH FLOW-CYTOMETRY
Garcia, C. F., Weiss, L. M., Lowder, J., KOMOROSKE, C., Link, M. P., & Warnke, R. A. (1987). QUANTITATION AND ESTIMATION OF LYMPHOCYTE SUBSETS IN TISSUE-SECTIONS - COMPARISON WITH FLOW-CYTOMETRY. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 87(4), 470-477.

ESTABLISHMENT AND CHARACTERIZATION OF A COMMON ACUTE LYMPHOBLASTIC-LEUKEMIA CELL-LINE WITH A DELETION OF CHROMOSOME-3 BAND Q26
Smith, S. D., Morgan, R., Galili, N., Amylon, M. D., Link, M. P., & Glader, B. E. (1987). ESTABLISHMENT AND CHARACTERIZATION OF A COMMON ACUTE LYMPHOBLASTIC-LEUKEMIA CELL-LINE WITH A DELETION OF CHROMOSOME-3 BAND Q26. CANCER RESEARCH, 47(6), 1652-1656.

Postremission induction intensive sequential chemotherapy for children with AML--treatment results and prognostic factors.
Weinstein, H., Grier, H., Gelber, R., Camitta, B., Link, M., & Price, K. (1987). Postremission induction intensive sequential chemotherapy for children with AML--treatment results and prognostic factors. Haematology and blood transfusion, 30, 88-92.

A UNIQUE ANTIGEN ON MATURE B-CELLS DEFINED BY A MONOCLONAL-ANTIBODY
Link, M. P., Bindl, J., MEEKER, T. C., CARSWELL, C., DOSS, C. A., & Levy, R. (1986). A UNIQUE ANTIGEN ON MATURE B-CELLS DEFINED BY A MONOCLONAL-ANTIBODY. JOURNAL OF IMMUNOLOGY, 137(9), 3013-3018.

COMMON MECHANISM OF CHROMOSOME INVERSION IN B-CELL AND T-CELL TUMORS - RELEVANCE TO LYMPHOID DEVELOPMENT
Denny, C. T., Hollis, G. F., Hecht, F., Morgan, R., Link, M. P., & Kirsch, I. R. (1986). COMMON MECHANISM OF CHROMOSOME INVERSION IN B-CELL AND T-CELL TUMORS - RELEVANCE TO LYMPHOID DEVELOPMENT. SCIENCE, 234(4773), 197-200.

CHROMOSOME-9 ABNORMALITIES IN CHILDHOOD T-CELL LEUKEMIA
Smith, S. D., Link, M. P., Trela, M., Amylon, M., Sklar, J., & Hecht, F. (1986). CHROMOSOME-9 ABNORMALITIES IN CHILDHOOD T-CELL LEUKEMIA. NEW ENGLAND JOURNAL OF MEDICINE, 315(3), 195-196.

THE EFFECT OF ADJUVANT CHEMOTHERAPY ON RELAPSE-FREE SURVIVAL IN PATIENTS WITH OSTEOSARCOMA OF THE EXTREMITY
Link, M. P., Goorin, A. M., Miser, A. W., Green, A. A., Pratt, C. B., & Vietti, T. J. (1986). THE EFFECT OF ADJUVANT CHEMOTHERAPY ON RELAPSE-FREE SURVIVAL IN PATIENTS WITH OSTEOSARCOMA OF THE EXTREMITY. NEW ENGLAND JOURNAL OF MEDICINE, 314(25), 1600-1606.

CHRONIC INFECTIOUS-MONONUCLEOSIS SYNDROME, PANCYTOPENIA, AND POLYCLONAL B-LYMPHOPROLIFERATION TERMINATING IN ACUTE LYMPHOBLASTIC-LEUKEMIA
Finlay, J., Luft, B., Yousem, S., Wood, G. S., Link, M., & PURTILO, D. (1986). CHRONIC INFECTIOUS-MONONUCLEOSIS SYNDROME, PANCYTOPENIA, AND POLYCLONAL B-LYMPHOPROLIFERATION TERMINATING IN ACUTE LYMPHOBLASTIC-LEUKEMIA. AMERICAN JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 8(1), 18-27.

CHROMOSOME CLUES TO ACUTE-LEUKEMIA IN DOWNS-SYNDROME
Hecht, F., Hecht, B. K., Morgan, R., SANDBERG, A. A., & Link, M. P. (1986). CHROMOSOME CLUES TO ACUTE-LEUKEMIA IN DOWNS-SYNDROME. CANCER GENETICS AND CYTOGENETICS, 21(2), 93-98.

CYTOGENETIC AND IMMUNOPHENOTYPIC ANALYSIS OF CELL-LINES ESTABLISHED FROM PATIENTS WITH T-CELL LEUKEMIA LYMPHOMA
Smith, S. D., Morgan, R., Link, M. P., McFall, P., & Hecht, F. (1986). CYTOGENETIC AND IMMUNOPHENOTYPIC ANALYSIS OF CELL-LINES ESTABLISHED FROM PATIENTS WITH T-CELL LEUKEMIA LYMPHOMA. BLOOD, 67(3), 650-656.

LYMPHOBLASTIC LYMPHOMA - AN IMMUNOPHENOTYPE STUDY OF 26 CASES WITH COMPARISON TO T-CELL ACUTE LYMPHOBLASTIC-LEUKEMIA
Weiss, L. M., BINDL, J. M., Picozzi, V. J., Link, M. P., & Warnke, R. A. (1986). LYMPHOBLASTIC LYMPHOMA - AN IMMUNOPHENOTYPE STUDY OF 26 CASES WITH COMPARISON TO T-CELL ACUTE LYMPHOBLASTIC-LEUKEMIA. BLOOD, 67(2), 474-478.

MEDIASTINAL NONLYMPHOBLASTIC LYMPHOMAS IN CHILDREN - A CLINICOPATHOLOGICAL STUDY
Bunin, N. J., Hvizdala, E., Link, M., Callihan, T. R., HUSTU, H. O., & Murphy, S. B. (1986). MEDIASTINAL NONLYMPHOBLASTIC LYMPHOMAS IN CHILDREN - A CLINICOPATHOLOGICAL STUDY. JOURNAL OF CLINICAL ONCOLOGY, 4(2), 154-159.

Adjuvant therapy in the treatment of osteosarcoma.
Link, M. P. (1986). Adjuvant therapy in the treatment of osteosarcoma. Important advances in oncology, 193-207.

CONSERVATIVE MANAGEMENT OF TESTICULAR ENDODERMAL SINUS TUMOR IN CHILDHOOD
Carroll, W. L., Kempson, R. L., GOVAN, D. E., Freiha, F. S., Shochat, S. J., & Link, M. P. (1985). CONSERVATIVE MANAGEMENT OF TESTICULAR ENDODERMAL SINUS TUMOR IN CHILDHOOD. JOURNAL OF UROLOGY, 133(6), 1011-1014.

IMMUNOLOGICAL SELECTION OF HEMATOPOIETIC PRECURSOR CELLS UTILIZING ANTIBODY-MEDIATED PLATE BINDING (PANNING)
Greenberg, P. L., Baker, S., Link, M., & Minowada, J. (1985). IMMUNOLOGICAL SELECTION OF HEMATOPOIETIC PRECURSOR CELLS UTILIZING ANTIBODY-MEDIATED PLATE BINDING (PANNING). BLOOD, 65(1), 190-197.

ABNORMAL HELPER - SUPPRESSOR T-CELL RATIO IN THE STAFF OF A PEDIATRIC HOSPITAL
Somma, C., Miller, J. J., Silverman, E. D., & Link, M. P. (1985). ABNORMAL HELPER - SUPPRESSOR T-CELL RATIO IN THE STAFF OF A PEDIATRIC HOSPITAL. NEW ENGLAND JOURNAL OF MEDICINE, 312(24), 1573-1574.

LEUKEMIA WITH DOWNS-SYNDROME - TRANSLOCATION BETWEEN CHROMOSOME-1 AND CHROMOSOME-19 IN ACUTE MYELOMONOCYTIC LEUKEMIA FOLLOWING TRANSIENT CONGENITAL MYELOPROLIFERATIVE SYNDROME
Morgan, R., Hecht, F., Cleary, M. L., Sklar, J., & Link, M. P. (1985). LEUKEMIA WITH DOWNS-SYNDROME - TRANSLOCATION BETWEEN CHROMOSOME-1 AND CHROMOSOME-19 IN ACUTE MYELOMONOCYTIC LEUKEMIA FOLLOWING TRANSIENT CONGENITAL MYELOPROLIFERATIVE SYNDROME. BLOOD, 66(6), 1466-1468.

DISCORDANCE BETWEEN SURFACE AND CYTOPLASMIC EXPRESSION OF THE LEU-4 (T3) ANTIGEN IN THYMOCYTES AND IN BLAST CELLS FROM CHILDHOOD T-LYMPHOBLASTIC MALIGNANCIES
Link, M. P., Stewart, S. J., Warnke, R. A., & Levy, R. (1985). DISCORDANCE BETWEEN SURFACE AND CYTOPLASMIC EXPRESSION OF THE LEU-4 (T3) ANTIGEN IN THYMOCYTES AND IN BLAST CELLS FROM CHILDHOOD T-LYMPHOBLASTIC MALIGNANCIES. JOURNAL OF CLINICAL INVESTIGATION, 76(1), 248-253.

NON-HODGKINS LYMPHOMA IN CHILDREN
Link, M. P. (1985). NON-HODGKINS LYMPHOMA IN CHILDREN. PEDIATRIC CLINICS OF NORTH AMERICA, 32(3), 699-720.

ACUTE LEUKEMIAS ASSOCIATED WITH THE 4-11 CHROMOSOME-TRANSLOCATION HAVE REARRANGED IMMUNOGLOBULIN HEAVY-CHAIN GENES
Crist, W. M., Cleary, M. L., GROSSI, C. E., Prasthofer, E. F., HEGGIE, G. D., & Sklar, J. (1985). ACUTE LEUKEMIAS ASSOCIATED WITH THE 4-11 CHROMOSOME-TRANSLOCATION HAVE REARRANGED IMMUNOGLOBULIN HEAVY-CHAIN GENES. BLOOD, 66(1), 33-38.

A UNIQUE HUMAN LYMPHOCYTE-B ANTIGEN DEFINED BY A MONOCLONAL-ANTIBODY
MEEKER, T. C., MILLER, R. A., Link, M. P., Bindl, J., Warnke, R., & Levy, R. (1984). A UNIQUE HUMAN LYMPHOCYTE-B ANTIGEN DEFINED BY A MONOCLONAL-ANTIBODY. HYBRIDOMA, 3(4), 305-320.

THYROID-DYSFUNCTION AFTER RADIOTHERAPY IN CHILDREN WITH HODGKINS-DISEASE
Constine, L. S., Donaldson, S. S., McDougall, I. R., Cox, R. S., Link, M. P., & KAPLAN, H. S. (1984). THYROID-DYSFUNCTION AFTER RADIOTHERAPY IN CHILDREN WITH HODGKINS-DISEASE. CANCER, 53(4), 878-883.

IMMUNE THROMBOCYTOPENIA ASSOCIATED WITH ACUTE NONLYMPHOCYTIC LEUKEMIA
Amylon, M. D., Link, M. P., & Glader, B. E. (1984). IMMUNE THROMBOCYTOPENIA ASSOCIATED WITH ACUTE NONLYMPHOCYTIC LEUKEMIA. JOURNAL OF PEDIATRICS, 105(5), 776-778.

PAN-LEUKOCYTE MONOCLONAL ANTIBODY-L3B12 - CHARACTERIZATION AND APPLICATION TO RESEARCH AND DIAGNOSTIC PROBLEMS
Wood, G. S., Link, M., Warnke, R. A., Dilley, J., & Levy, R. (1984). PAN-LEUKOCYTE MONOCLONAL ANTIBODY-L3B12 - CHARACTERIZATION AND APPLICATION TO RESEARCH AND DIAGNOSTIC PROBLEMS. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 81(2), 176-183.

MONOCLONAL-ANTIBODY AND ENZYMATIC PROFILES OF HUMAN-MALIGNANT LYMPHOID-T CELLS AND DERIVED CELL-LINES
Smith, S. D., Shatsky, M., Cohen, P. S., Warnke, R., Link, M. P., & Glader, B. E. (1984). MONOCLONAL-ANTIBODY AND ENZYMATIC PROFILES OF HUMAN-MALIGNANT LYMPHOID-T CELLS AND DERIVED CELL-LINES. CANCER RESEARCH, 44(12), 5657-5660.

ACUTE NONLYMPHOCYTIC LEUKEMIA DEVELOPING DURING THE COURSE OF EWINGS-SARCOMA
Link, M. P., Donaldson, S. S., Kempson, R. L., Wilbur, J. R., & Glader, B. E. (1984). ACUTE NONLYMPHOCYTIC LEUKEMIA DEVELOPING DURING THE COURSE OF EWINGS-SARCOMA. MEDICAL AND PEDIATRIC ONCOLOGY, 12(3), 194-200.

PROGNOSTIC-SIGNIFICANCE OF COMPLETE SURGICAL RESECTION OF PULMONARY METASTASES IN PATIENTS WITH OSTEOGENIC-SARCOMA - ANALYSIS OF 32 PATIENTS
Goorin, A. M., DELOREY, M. J., Lack, E. E., Gelber, R. D., Price, K., & Abelson, H. T. (1984). PROGNOSTIC-SIGNIFICANCE OF COMPLETE SURGICAL RESECTION OF PULMONARY METASTASES IN PATIENTS WITH OSTEOGENIC-SARCOMA - ANALYSIS OF 32 PATIENTS. JOURNAL OF CLINICAL ONCOLOGY, 2(5), 425-431.

IDENTIFICATION AND SIGNIFICANCE OF CELL MARKERS IN LEUKEMIA AND LYMPHOMA
Warnke, R. A., & Link, M. P. (1983). IDENTIFICATION AND SIGNIFICANCE OF CELL MARKERS IN LEUKEMIA AND LYMPHOMA. ANNUAL REVIEW OF MEDICINE, 34, 117-131.

CRANIAL NERVE INVOLVEMENT IN CHILDREN WITH LEUKEMIA AND LYMPHOMA
PARYANI, S. B., Donaldson, S. S., Amylon, M. D., & Link, M. P. (1983). CRANIAL NERVE INVOLVEMENT IN CHILDREN WITH LEUKEMIA AND LYMPHOMA. JOURNAL OF CLINICAL ONCOLOGY, 1(9), 542-545.

CUTANEOUS LYMPHOBLASTIC LYMPHOMA WITH PRE-B MARKERS
Link, M. P., Roper, M., Dorfman, R. F., Crist, W. M., COOPER, M. D., & Levy, R. (1983). CUTANEOUS LYMPHOBLASTIC LYMPHOMA WITH PRE-B MARKERS. BLOOD, 61(5), 838-841.

A SINGLE MONOCLONAL-ANTIBODY IDENTIFIES T-CELL LINEAGE OF CHILDHOOD LYMPHOID MALIGNANCIES
Link, M., Warnke, R., Finlay, J., Amylon, M., Miller, R., & Levy, R. (1983). A SINGLE MONOCLONAL-ANTIBODY IDENTIFIES T-CELL LINEAGE OF CHILDHOOD LYMPHOID MALIGNANCIES. BLOOD, 62(4), 722-728.

METHOTREXATE-INDUCED RENAL IMPAIRMENT - CLINICAL-STUDIES AND RESCUE FROM SYSTEMIC TOXICITY WITH HIGH-DOSE LEUCOVORIN AND THYMIDINE
Abelson, H. T., FOSBURG, M. T., Beardsley, P., Goorin, A. M., Gorka, C., & Link, D. (1983). METHOTREXATE-INDUCED RENAL IMPAIRMENT - CLINICAL-STUDIES AND RESCUE FROM SYSTEMIC TOXICITY WITH HIGH-DOSE LEUCOVORIN AND THYMIDINE. JOURNAL OF CLINICAL ONCOLOGY, 1(3), 208-216.

High-dose methotrexate in osteogenic sarcoma.
Jaffe, N., Link, M. P., Cohen, D., TRAGGIS, D., FREI, E., & Abelson, H. T. (1981). High-dose methotrexate in osteogenic sarcoma. National Cancer Institute monograph, (56), 201-206.

FETAL-LIKE ERYTHROPOIESIS DURING RECOVERY FROM TRANSIENT ERYTHROBLASTOPENIA OF CHILDHOOD (TEC)
Link, M. P., & Alter, B. P. (1981). FETAL-LIKE ERYTHROPOIESIS DURING RECOVERY FROM TRANSIENT ERYTHROBLASTOPENIA OF CHILDHOOD (TEC). PEDIATRIC RESEARCH, 15(7), 1036-1039.

HIGH-DOSE METHOTREXATE IN OSTEOGENIC-SARCOMA ADJUVANT CHEMOTHERAPY AND LIMB SALVAGE RESULTS
Jaffe, N., Goorin, A., Link, M., Watts, H., Frei, E., & Abelson, H. T. (1981). HIGH-DOSE METHOTREXATE IN OSTEOGENIC-SARCOMA ADJUVANT CHEMOTHERAPY AND LIMB SALVAGE RESULTS. CANCER TREATMENT REPORTS, 65, 99-106.

NON-HODGKINS LYMPHOMA IN CHILDHOOD
Weinstein, H. J., & Link, M. P. (1979). NON-HODGKINS LYMPHOMA IN CHILDHOOD. CLINICS IN HAEMATOLOGY, 8(3), 699-716.